Advertisement

Angina Pectoris

Chapter
  • 271 Downloads
Part of the Treatment in Clinical Medicine book series (TC MEDICINE)

Abstract

Angina pectoris is a symptom complex due to reversible myocardial ischaemia The diagnosis must not be made casually. The symptoms are those of chest pain or tightness which can radiate to either or both arms, throat or back. Pain is brought on by effort or emotion or may occur spontaneously at rest.

Keywords

Angina Pectoris Unstable Angina Isosorbide Dinitrate Coronary Spasm Isosorbide Mononitrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153: 586PubMedGoogle Scholar
  2. Balasubramanian V, Lamiri A, Sivam P, Raftery EB (1980) Anti-anginal action of verapamil — a controlled study. Am J Cardiol 45: 389 (ABS)CrossRefGoogle Scholar
  3. Bergman G, Atkinson L, Richardson PJ, Daly K, Rothman M, Jackson G, Jewitt DE (1981) Prostacyclin: Haemodynamic and metabolic effects in patients with coronary artery disease. Lancet I: 569–572CrossRefGoogle Scholar
  4. Blumenthal HP, Fung ML, McNiff EF, Yap SK (1977) Plasma nitroglycerin levels after sublingual, oral and topical administration. Br J Clin Pharmacol 4: 241–242PubMedGoogle Scholar
  5. Bobik A, Jennings GL, Korner PI, Ashley P, Jackman G (1979) Absorption and excretion of rapid and slow release oxprenolol and their effects on heart rate and blood pressure during exercise. Br J Clin Pharmacol 7: 545–549PubMedGoogle Scholar
  6. Bott-Silverman C, Heupler FA (1983) Natural history of pure coronary spasm in patients treated medically. J Am Coll Cardiol 2: 200–205PubMedCrossRefGoogle Scholar
  7. Ebner F, Dunschede HB (1976) Haemodynamics, therapeutic mechanism of action and clinical findings of Adalat use based on world wide clinical trials. In: Domingos A, Lichtlen PR (eds) Third International Adalat Symposium. Excerpta Medica, Amsterdam Oxford, p 283Google Scholar
  8. Editorial (1981) Prostacyclin in therapeutics. Lancet I: 643Google Scholar
  9. Greenblatt DJ, Koch-Weser J (1973) Adverse reactions to propranolol in hospitalised medical patients: a report from the Boston collaborative drug surveillance program. Am Heart J 86: 478–484PubMedCrossRefGoogle Scholar
  10. Hoffman BB, Lefkowitz RJ (1980) Alpha adrenergic subtypes. N Engl J Med 302: 1390–1396PubMedCrossRefGoogle Scholar
  11. Jackson G, Schwartz J, Kates RE, Winchester M, Harrison DC (1980) Atenolol: once daily cardioselective beta blockade for angina pectoris. Circulation 61: 555–560PubMedGoogle Scholar
  12. Johnsson G, Svedmyr N, Thiringer G (1975) Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics. Eur J Clin Pharmacol 6: 175–180CrossRefGoogle Scholar
  13. Kennedy CC (1976) One year graduated exercise program for men with angina pectoris. Mayo Clin Proc 51(4): 231–236PubMedGoogle Scholar
  14. Lands AM, Adnold A, McAuliff JR, Ludvena FP, Brown TG (1967) Differentation of receptor systems activated by sympathomimetic amines. Nature 214: 597–598PubMedCrossRefGoogle Scholar
  15. Lee G, Mason DT, De Maria AN (1978) Effects of long term oral administration of isosorbide dinitrate on the anti-anginal response to nitroglycerin: absence of nitrate cross tolerance and self tolerance shown by exercise testing. Am J Cardiol 41: 82–87PubMedCrossRefGoogle Scholar
  16. Lewis HD, Davis JW, Archibald DG, Steinke WE (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans’ Administration Cooperative Study. N Engl J Med 309: 396–403PubMedCrossRefGoogle Scholar
  17. Lundborg P, Astrom H, Bengtsson C, Fellenius E, Von Schenr H, Suensson L, Smith U (1981) Effect of adrenoceptor blockade on exercise performance and metabolism. Clin Sci 61: 299-305PubMedGoogle Scholar
  18. Lynch P, Dargie H, Krikler S, Krikler D (1980) Objective assessment of antianginal treatment: A double blind comparison of propranolol, nifedipine and their combination. Br Med J 281: 184–187PubMedCrossRefGoogle Scholar
  19. Markis JE, Gorlin R, Hills M, Williams RA, Schweitzer P, Ransil BJ (1979) Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris. Am J Cardiol 43: 265–271PubMedCrossRefGoogle Scholar
  20. Maseri A (1980) Pathogenic mechanisms in angina pectoris. Br Heart J 43: 648–660PubMedCrossRefGoogle Scholar
  21. Maseri A, Severi S, DeNes M et al. (1978) “Variant” angina: one aspect of a continuous spectrum of vasospastic myocardial ischaemia. Am J Cardiol 42: 1019–1035PubMedCrossRefGoogle Scholar
  22. McAllister RG (1982) Clinical pharmacology of slow channel blocking agents. Prog Cardiovasc Dis 25: 83–102PubMedCrossRefGoogle Scholar
  23. McIlmoyle EL, Blair ALT, Calvert HWA, Boyle DMc, Shanks RG, Leaney W, Barber JM (1979) Studies with a slow release formulation of propranolol in angina. J Irish Med Assoc 72:27–28Google Scholar
  24. McSorley PD, Warren DJ (1978) Effects of propranolol and metaprolol on the peripheral circulation. Br Med J II: 1598–1600CrossRefGoogle Scholar
  25. Miller RR, Olson HG, Amsterdam EA, Mason DT (1975) Propranolol — withdrawal rebound phenomenon. N Engl J Med 293: 416–418PubMedCrossRefGoogle Scholar
  26. Motulsky HJ, Insel PA (1982) Adrenergic receptors in man. N Engl J Med 307: 18PubMedCrossRefGoogle Scholar
  27. MRC Working Party on Mild to Moderate Hypertension (1981) Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet II: 539–543Google Scholar
  28. Needleman P, Lang S, Johnson EM (1972) Organic nitrates: relation between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 181: 489–497PubMedGoogle Scholar
  29. Redwood DR, Rosing DR, Epstein SE (1972) Circulatory and symptomatic effects of physical training in patients with coronary artery disease and angina pectoris. N Engl J Med 286: 959–965PubMedCrossRefGoogle Scholar
  30. Uusitalo AS, Keyrilainen O (1979) Slow release metoprolol in angina pectoris. Ann Clin Res II: 199–203Google Scholar
  31. Veterans’ Administration Co-operative Study (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 309: 396–403CrossRefGoogle Scholar
  32. Waters DD, Bouchard A, Theroux P (1983) Spontaneous remission is a frequent outcome of variant angina. J Am Coll Cardiol 2: 195–197PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  1. 1.Royal InfirmaryGlasgowScotland, UK
  2. 2.Stobhill General HospitalGlasgowScotland, UK

Personalised recommendations